The Marseille company Proverpharm can sell its drugs in the United States
It’s a great victory for the Marseille company. Specializing in the development of pharmaceutical products, Provepharm has just obtained marketing authorization from the US Food & Drug Administration for Bludigo, its new drug, the first injectable indigo carmine registered in the United States. This injectable dye is indicated as an aid to visualization in the cystoscopic evaluation (endoscopy of the bladder) of the integrity of the ureters in adults during open, robotic or endoscopic urological and gynecological surgical procedures.And also Succession of Didier Raoult at the IHU Méditerranée: Pierre-Édouard Fournier challenged by the unions&quo